Previous 10 | Next 10 |
VANCOUVER and MINNEAPOLIS, March 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc , Inc. ("Neovasc" or the "Company") ( NASDAQ , TSX : NVCN) today announced that the journal Clinical Cardiology has published an article entitled, “Long-term outcomes of pati...
Nasdaq notified Neovasc (NVCN) that it has regained compliance with the minimum market value requirement.The company had received non compliance in December 2020.Shares trading -0.62% down after hours For further details see: Neovasc regains Nasdaq compliance
VANCOUVER, Feb. 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. ( NASDAQ , TSX : NVCN), today announced that company management will be participating in the 10 th Annual SVB Leerink Global Healthcare Conference that is scheduled to take plac...
Neovasc ([[NVCN]] +4.0%) has closed its previously announced sale of an aggregate of 36M shares at a purchase price of $2/share in a registered direct offering priced at-the-market, with gross proceeds of about $72M.Each common share was sold with 0.50 of a purchase warrant, with ea...
VANCOUVER, CANADA, Feb. 12, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq: NVCN / TSX: NVCN) announced today that it has closed its previously announced sale of an aggregate of 36,000,000 common ...
Gainers: Bio-Path Holdings (BPTH) +253%.Cancer Genetics (CGIX) +74%.Torchlight Energy Resources (TRCH) +73%.CM Life Sciences (CMLF) +51%.India Globalization Capital (IGC) +42%.Anchiano Therapeutics (ANCN) +42%.The OLB Group (OLB) +41%.Sundial Growers (SNDL) +40%.Clever Lea...
Comstock Holding Companies (CHCI) -15%.VerifyMe (VRME) -15% on stock offering.Neovasc (NVCN) -14% on stock offering; pared yesterday's gains on patent news.Enlivex Therapeutics (ENLV) -13% on stock offering.Salem Media Group (SALM) -13%.Limbach Holdings (LMB) ...
Neovasc (NVCN) inks agreements with institutional investors for the sale of 36M common shares at $2.00/share in a registered direct offering priced at-the-market.Gross proceeds are ~$72M. Each common share is being sold with 0.50 of a common share purchase warrant, which will entitle the hold...
Neovasc (NVCN) entered into definitive agreements with certain healthcare-focused institutional investors for the sale of 36M shares at $2/share in a registered direct offering priced at-the-market.Each common share is being sold with 0.50 of a common share purchase warrant; each warrant hold...
Vancouver, Canada, Feb. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq: NVCN / TSX: NVCN) announced today that it has entered into definitive agreements with certain healthcare-focused institutional investor...
News, Short Squeeze, Breakout and More Instantly...
Neovasc Inc. (NASDAQ: NVCN) is the focus of IBN's latest stock spotlight. The company's shares have moved -1.48% on the day to $29.23. Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. It...
VANCOUVER and MINNEAPOLIS, MN, March 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today reported financial results for the fourth quarter and year ended December 31, 2022. Recent Hi...
VANCOUVER, BC, March 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive devices for the treatment of refractory angina, is pleased to announce that its Shareholders (as d...